Superoxide anion radicals induce IGF-1 resistance through concomitant activation of PTP1B and PTEN

Karmveer Singh1, Pallab Maity1, Linda Krug1

  • 1Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany Aging Research Center (ARC), Ulm, Germany.

EMBO Molecular Medicine
|December 19, 2014
PubMed

Insights

Mitochondrial superoxide anions suppress Insulin-like Growth Factor 1 (IGF-1) signaling, impacting skin aging. Inhibiting phosphatases PTP1B and PTEN reverses this resistance, offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Aging Research
  • Biochemistry

Background:

  • The Insulin-like Growth Factor 1 (IGF-1) signaling pathway is crucial for longevity, metabolism, tissue homeostasis, and cancer.
  • Regulation of IGF-1 signaling involves a complex interplay of kinases and phosphatases, with mechanisms not fully elucidated.
  • Mitochondrial dysfunction, specifically superoxide anion (O2∙-) accumulation, is implicated in aging and disease.

Purpose of the Study:

  • To investigate the impact of mitochondrial superoxide anions (O2∙-) on IGF-1 signaling.
  • To identify the molecular mechanisms by which O2∙- suppresses IGF-1 signaling.
  • To explore the potential of targeting key phosphatases for therapeutic intervention in aging-related pathologies.

Main Methods:

  • In vitro and in vivo studies using a murine aging model.
  • Chemical inhibition of mitochondrial complex I and genetic silencing of mitochondrial Sod2 to induce O2∙- accumulation.
  • Analysis of fibroblast proliferation, translation initiation factors, collagen expression, and phosphatase activity (PTP1B, PTEN).
  • Genetic and pharmacologic inhibition of PTP1B and PTEN.

Main Results:

  • Accumulation of mitochondrial superoxide anions (O2∙-) suppressed IGF-1 signaling.
  • This suppression led to reduced murine dermal fibroblast proliferation, altered translation initiation, and decreased collagen expression, characteristic of skin aging.
  • O2∙- activated phosphatases PTP1B and PTEN, which dephosphorylated the IGF-1 receptor and phosphatidylinositol 3,4,5-triphosphate, dampening IGF-1 signaling.
  • Inhibition of PTP1B and PTEN reversed O2∙--induced IGF-1 resistance and ameliorated the skin aging phenotype.

Conclusions:

  • Mitochondrial superoxide anions (O2∙-) are key regulators that suppress IGF-1 signaling through PTP1B and PTEN activation.
  • This O2∙--mediated suppression contributes to the molecular hallmarks of skin aging.
  • Targeting O2∙-, PTP1B, and PTEN represents a promising therapeutic strategy to combat IGF-1 resistance and related aging pathologies.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K